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Background: Outbreaks in poultry involving influenza virus from H7 subtype have resulted in human infections,
thus causing a major concern for public health, as well as for the poultry industry. Currently, no efficient rapid test
is available for large-scale detection of either antigen or antibody of H7 avian influenza viruses.
Results: In the present study, a dual function ELISA was developed for the effective detection of antigen and
antibody against H7 AIVs. The test was established based on antigen-capture-ELISA and epitope blocking ELISA. The
two Mabs 62 and 98 which were exploited in the assay were identified to recognize two conformational
neutralizing epitopes on H7 HA1. Both of the epitopes exist in all of the human H7 strains, including the recent
H7N9 strain from China and > 96.6% of avian H7 strains. The dual ELISA was able to detect all of the five H7
antigens tested without any cross reaction to other influenza subtypes. The antigen detection limit was less than 1
HA unit of H7. For antibody detection, the sensitivity and specificity of the dual ELISA was evaluated and compared
to HI and microneutralization using immunized animal sera to different H7 strains and different subtypes of AIVs.
Results indicated that antibodies to H7 were readily detected in immunized animal sera by the dual ELISA whereas
specimens with antibodies to other AIVs yielded negative results.
Conclusions: This is the first dual-function ELISA reported for either antigen or antibody detection against H7 AIVs.
The assay was highly sensitive and 100% specific in both functions rendering it effective for H7 diagnosis.
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Recurrence of highly pathogenic avian influenza (HPAI)
virus subtype H7 in humans and poultry continues to be
a serious concern to public health. Before 2002, only
occasional case reports of human H7 influenza virus in-
fections occurred as a result of direct animal-to-human
transmission or laboratory accidents and most of these
infections resulted in conjunctivitis and/or mild influenza-
like illness [1]. In 2003, an HPAI H7N7 outbreak in the
Netherlands infected 89 people who were in close contact
with affected poultry, including one fatal case, and led to
the culling of over 30 million birds [2]. The most recent* Correspondence: kwang@tll.org.sg
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reproduction in any medium, provided the oroutbreak of H7N9 strains in China resulted in more than
130 human cases, including 36 deaths, making H7 subtype
HPAI viruses the focus of public attention [3]. WHO has
listed HPAI H7N9 as one of the most lethal viral patho-
gens [4]. Most of the infected patients had a history of
poultry contact, indicating the transmission from poultry
to human. The scale of poultry outbreaks and its associ-
ation with cases of human infection with H7 viruses high-
lights the need for efficient diagnosis and continued
surveillance of this virus subtype [5].
Conventional laboratory methods for influenza virus
detection include virus isolation in embryonated eggs or
Madin-Darby canine kidney (MDCK) cells, followed by
subsequent HA subtype identification using serological
methods. Molecular detection methods such as real-time
PCR assays have been widely applied for the laboratoryThis is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 HI and neutralization (VN) titer of 62 and 98
(200 ug/ml) against different H7
Virus Subtype HI titer VN titer
(Mab 62, 98) (Mab 62, 98)
A/Chicken/Malaysia/94* H7N1 256, 256 640, 640
A/Canada/rv504/04 H7N3 128,256 320, 640
A/quail/Aichi/4/09 H7N6 64, 64 80, 80
A/duck/Hokkaido/1/10 H7N7 128, 256 320, 640
A/Netherlands/219/03 H7N7 256, 256 640, 1280
A/Shanghai/1/13* H7N9 64, 128 160, 320
A/Puerto Rico/8/34 H1N1 <8, <8 <20, <20
A/TLL51/Singapore/09 H1N1 <8, <8 <20, <20
A/duck/Nanchang/4-184/2000 H2N9 <8, <8 <20, <20
A/Chicken/Malaysia/02* H3N2 <8, <8 <20, <20
A/Chicken/Malaysia/92* H4N1 <8, <8 <20, <20
A/Vietnam/VN1203/03 H5N1 <8, <8 <20, <20
A/Shorebird/DE/12/04 H6N8 <8, <8 <20, <20
A/duck/Yangzhou/02/05 H8N4 <8, <8 <20, <20
A/chicken/Malaysia/98* H9N2 <8, <8 <20, <20
A/mandarin duck/Malaysia/98* H10N5 <8, <8 <20, <20
A/pintail/Alberta/84/2000 H11N9 <8, <8 <20, <20
A/pintail/Alberta/49/03 H12N5 <8, <8 <20, <20
A/gull/Maryland/704/1977 H13N6 <8, <8 <20, <20
HI titer below 8 and VN titer below 20 indicated negative activity. *: wild
type virus.
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identification [8]. However, both conventional and
laboratory methods are technically demanding and are
not suitable for on-site use in field investigations. The
development of rapid H7 subtype influenza virus de-
tection tests in dot ELISA (enzyme-linked immuno-
sorbent assay) [9], AC-ELISA (antigen-capture ELISA),
and chromatographic strip formats [10] using H7 mono-
clonal antibodies (MAbs) is hence preferred.
Serological investigations to detect specific antibodies
from H7 infection in poultry and humans are critical to
the success of disease prevention and control programs.
However, due to the lack of a specific and sensitive
monoclonal antibody, there are no serologic tests avail-
able against H7 AIV. Microneutralization is currently
used as the “gold standard” for subtyping. However, the
test is labor-intensive and its sensitivity is limited,
rendering it impractical for rapid and high-throughput
diagnostics. The HI test and indirect ELISA are consi-
dered to be simple serology tests. However, low sensi-
tivity and subtype cross-reactivity significantly limit the
value of these assays [11]. Competitive ELISAs (cELISA),
also called epitope blocking ELISAs, are widely used for
serological detection of antibodies to influenza viruses
[12], mainly due to their sensitivity and simplicity. The
cELISA makes it possible to provide general assays
for testing sera from different avian species, humans,
and other species without changing any of the test re-
agents [13].
It is a challenge to combine AC-ELISA and cELISA on
the same plate with the same amount of antibodies. The
selected Mabs are required to target conserved antigenic
epitopes and compete to host antibodies in infected sera
for the epitope binding. In this study, two H7 Mabs were
identified to meet these requirements and assembled in
a dual-function-ELISA for universal H7 diagnosis via
either antigen or antibody detection. The sensitivity and
specificity for both functions were evaluated. The results
indicated that for the first time, antigen and antibody
detection could be performed with the same device and
Mabs for specific and sensitive H7 AIV detection.
Methods
Ethics statement
All animal experiments were carried out in accordance
with the Guidelines for Animal Experiments of the
National Institute of Infectious Diseases (NIID). Experi-
mental protocols were reviewed and approved by Institu-
tional Animal Care and Use Committee of the Temasek
Life Sciences Laboratory, National University of Singapore,
Singapore. (IACUC approval number TLL-10-012).
All experiments involving human H7 strains were
performed in a biosafety level 3 (BSL-3) containment
laboratory in compliance with CDC/NIH and WHOrecommendations and were approved by the Agri
Veterinary Authority (AVA) of Singapore.
Viruses and cell lines
The viruses used were listed in Table 1. H7N1 (A/
Chicken/Malaysia/94) and part of other non-H7 AIV
strains were obtained from the Agri-Food and Veterinary
Authority of Singapore. Reassortant influenza virus H7N3
(A/Canada/rv504/04), H7N6 (A/quail/Aichi/3/09), H7N7
(A/duck/Hokkaido/1/10), H7N7 (A/Netherlands/219/03),
H2, H6, H8, H11-H13, H5N1 (A/Vietnam/VN1203/03/)
and H1N1 (A/TLL51/Singapore/09) were generated by
reverse genetics as described previously [14]. Briefly, the
complementary DNA of the HA and NA genes of influ-
enza viruses were synthesized based on the sequences
from the NCBI influenza database while the six cDNAs of
the internal genes were synthesized based on the PR8
(A/Puerto Rico/8/1934) virus sequence (GenScript, USA).
The cDNA of each of the eight influenza virus gene seg-
ments was inserted between the pol I promoter (pIh) and
the pol I terminator of pClpolsaplT vector (kindly pro-
vided by Ruben Donis, CDC, USA) and cotransfected into
cocultured 293 T human embryonic kidney cells and
Madin–Darby canine kidney (MDCK) cells using lipo-
fectamine 2000 (Life Technologies, USA). MDCK cells
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(DMEM; Life Technologies, USA) containing 10% Fetal
Bovine Serum (FBS; Life Technologies, USA). 293 T
were maintained in Opti-MEMI (Life Technologies, USA)
containing 5% FBS. After 48 h the transfected super-
natants were collected and virus titers were determined by
standard hemagglutination assays. The sequences were
confirmed using a specific set of universal primers as
described previously (21). Viruses were propagated in
10 day old specific pathogen free embroyonated chicken
eggs at 37°C. The tissue culture infectious dose 50
(TCID50) of reassortant virus was then calculated by the
Muench-Reed method (1938).
Production and characterization of Mab
BALB/c mice were immunized twice subcutaneously at
intervals of 2 weeks with BEI (binary ethylenimine)
inactivated H7N1 (A/Chicken/Malaysia/94) and adjuvant
(SEPPIC, France). Mice were boosted with the same viral
antigen, 3 days before the fusion of splenocytes with SP2/
0 cells [15]. The fused cells were seeded in 96-well plates,
and their supernatants were screened by immunofluores-
cence assays as described below. The hybridomas that
produced the Mabs were cloned by limiting dilution at
least three times. The positive Mabs were tested for their
hemagglutination inhibition activity as described below.
Immunoglobulins from selected positive Mabs were
isotyped using a commercial isotyping kit (Amersham
Bioscience, England) as described in the manufacturer’s
protocol. The hybridoma suspension was harvested 3 days
postseeding and cell debris pelleted by centrifugation at
400 g for 10 min, followed by collection of the supernatant
and storage at −20°C. Mabs were purified with Montage
kit Prosep-G (Millipore) for IgG.
Experimental serum samples
Inactivated AI viruses (Table 1) were emulsified in ISA-70
(SEPPIC, France) adjuvant and injected intramuscu-
larly to the groups of three weeks old white leghorn
chickens (n = 4). The booster was given twice at two-
week intervals. Sera were prepared from the blood
collected 10 days after 1st injection and 2nd injection.
Antibody responses to the homologous strains were evalu-
ated by HI as described below. Groups of mice (n = 4)
were injected intramuscularly with different inactivated
H7 AIVs (Table 1) individually emulsified in adjuvant
(SEPPIC, France). The injections were repeated twice at
two-week intervals. In addition, guinea pigs were immu-
nized with inactivated H7N1 (A/Chicken/Malaysia/94).
Blood was collected 14 days after the 2nd immunization.
Hemagglutination inhibition assay
Hemagglutination inhibition (HI) assays were performed
as described previously [16]. Briefly, Mabs were seriallydiluted (2 fold) in V-bottom 96-well plates and mixed
with 4 HA units of H7 virus. Plates were incubated for
30 min at room temperature, and 1% chicken RBCs were
added to each well. The hemagglutination inhibition
endpoint was the highest Mab dilution in which agglu-
tination was not observed.
Isolation and analysis of escape mutants
The epitope recognized by Mab 62 was mapped by
characterization of escape mutants as described previ-
ously [9]. Briefly, H7N1 parental viruses were incubated
with an excess of Mab for 1 h and then inoculated into
11 day old embryonated chicken eggs. The eggs were in-
cubated at 37°C for 48 h. Virus was harvested and used
for cloning in limiting dilution in embryonated chicken
eggs and the escape mutants were plaque purified. The
HA gene mutations were then identified by sequencing
and comparison with the sequence of the parental virus.
Microneutralization assay
Neutralization activity of Mab against H7 strains was
analyzed by microneutralization assay as previously de-
scribed [17]. Briefly, Mab was serially two-fold diluted
and incubated with 100 TCID50 of different clades of
H7 strains for 1 h at room temperature and plated in
duplicate onto MDCK cells grown in a 96-well plate.
The neutralizing titer was assessed as the highest Mab
dilution in which no cytopathic effect was observed by
light microscopy.
H7 baculovirus production
The recombinant baculovirus vector was generated as
described previously [18]. The full length HA gene was
amplified from H7N7 (A/NL/219/03) reassortant virus
in a standard PCR reaction. The amplified HA gene
was inserted into the shuttle vector pFASTBacHT A
(Invitrogen, San Diego, CA, USA) for expression under
the white spot syndrome virus (WSSV) immediate early
(ie1) promotor. This expression cassette was integrated
into the baculovirus genome within DH10BacTM
(Invitrogen, USA) through site specific transposition
according to the protocol of the Bac-to-Bac system
(Invitrogen). SF9II cells were maintained in SF900II serum
free medium (Gibco BRL, USA) at 28°C for recombinant
baculovirus synthesis. The recombinant bacmid was then
transfected into SF9II cells and the supernatant containing
recombinant baculovirus displayed H7-HA (Bac-H7) was
harvested at 96 h post-infection.
Dual-function-ELISA
96-well, round-bottom microtiter plates (Nunc, Roskilde,
Demark) were coated with 0.5 ug/well of capture MAb
98 in 100 ul of carbonate buffer (73 mM sodium bicar-
bonate and 30 mM sodium carbonate, pH 9.7) overnight
Table 2 Epitope frequency in both human and avian H7
strains
Mab Amino acid Human frequency Avian frequency
98 136 Ser 100% 96.6%
137 Gly 100% 99.9%
62 175 Lys 100% 97.9%
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with PBST, followed by two washes with PBS after each
incubation with antibody or antigen. The antibody-
coated plates were blocked by incubation with 100 ul of
blocking buffer (PBS containing 5% milk) for 1 h at
room temperature. For antigen detection, the blocked
plates were then incubated at 37°C for 1 h with 100 ul of
virus-containing samples diluted in PBST. For antibody
detection, 50 ul of serum samples mixed with 50 ul of H7
surface expressing baculovirus of 8 HAU were added to
the blocked plates for 1-hour-incubation at 37°C. Virus
binding or antibody blocking was detected by incubation
for 1 h at 37°C with 100 ul of horseradish peroxidase-
conjugated detection MAb 62 (800 ng) (in-house label-
ing; Roche). Chromogen development was mediated by
the addition of 100 ul of freshly prepared substrate solu-
tion (o-phenylenediamine-dihydrochloride; Sigma). The
reaction was stopped with sulfuric acid of 0.1 N, and the
optical density at 490 nm was recorded. The antigen
detection limit was determined by the optical density
value that gave a signal-to-noise ratio of 3. For antibody
detection, the OD intensity reduction caused by serum
antibodies blocking Mab binding was calculated for each
sample dilution by using the formula: % inhibition =
[(negative reference serum OD-test serum OD)/(negative
reference serum OD-positive reference serum OD)]×100%.
To determine the cut-off value of antibody detection,
specific pathogen-free chicken sera, mice and guinea
pigs were obtained from the Animal Health Biotech-
nology Serum Bank, Temasek Life Sciences Laboratory,
Singapore.
Results
Mab 62 and 98 recognize conserved neutralizing epitopes
on H7 AIVs
A panel of Mabs against influenza hemagglutinin was
screened for efficient recognition of different strains
of H7 viruses. Based on the results of the HI assay and
virus neutralization (Table 1), Mab 62 and 98 were
selected for further studies due to their high HI activity
against a wide range of H7 viruses from birds and
humans, including strains from the recent H7N9 out-
break in eastern China. Both the Mabs belong to the
IgG1 isotype. The virus neutralizing activity of Mab 62
and 98 was further confirmed to be positive against H7
AIVs. Based on this, the amino acids involved in forming
the epitope of Mab 62 and 98 were analyzed using
selection of neutralization escape mutants. A/chicken/
Malaysia/94 H7N1 virus was used as parental virus for
the selection. Sequences of the complete HA genes iso-
lated from multiple escape variants were compared with
the parental virus. It was found that mutants generated
with Mab 62 have a single mutation on amino acid 175
from Lysine to Glutamate. Mab 98 carried mutationseither at amino acid 136 (Ser to Gly), or 137 (Gly to
Arg). The numbering of amino acid on HA starts from
“ATG” and includes the signal peptide.
In order to determine the significance of the neutra-
lization epitopes of Mab 62 and 98, the protein poly-
morphism of H7 was studied (Table 2), taking into
account all H7 sequences in the NCBI database. On the
175th amino acid, Lysine and Asparagine appear in more
than 99.9% of H7 AIV strains listed. Lysine is the most
dominant amino acid with the frequency of 97.9%
among avian H7 strains and 100% among human H7s.
On the 136th amino acid, Serine exists in 96.6% of avian
strains and 100% of human H7 strains, while Glycine on
the 137th amino acid exists in 99.9% of avian H7 and
100% of human strains. This finding indicates that the
two Mabs are able to recognize or neutralize all the H7
human strain identified so far, suggesting their potential
for universal H7 AIV detection.
Development of the dual-function-ELISA
The dual-function-ELISA was operated as shown in
Figure 1. H7 antigen can be detected in an AC-ELISA
based on H7 specific Mabs. Mab 62 was randomly
selected as the detector antibody and Mab 98 was used
as the capture antibody due to their equivalent perfor-
mance in the reversible use in H7 AC-ELISA. Optimal
concentrations of MAbs 62 and 98 for detection and
capture were determined by two-way titration of MAb
concentrations. The combination that gave the highest
signal-to-noise ratio was determined to be 0.5 ug/well of
capture MAb 98 and 0.9 ug/well of MAb 62 for detec-
tion. The tested virus was considered to be positive with
H7 antigen in the dual ELISA when the absorbance was
three times higher than that of the non-H7 viruses.
Serum antibodies to H7 can be detected by virtue of
their ability to block the recognition of the target epitope
by a H7 specific Mab in an ELISA assay. To combine
this assay to the AC-ELISA, serum samples were incu-
bated with the fixed amount of recombinant baculovirus,
which displays H7 on the virus surface, before being
loaded to the plate coated with the capture Mab. H7
antibody titers in samples were determined based on the
reduction of the detected H7 baculovirus. Different
concentrations of H7 baculovirus were tested before
confirming the optimal concentration at 8 HAU. Serum
panels from normal or H7 immunized chicken and mice
Figure 1 Procedures of both antigen and antibody detection in the dual-function-ELISA.
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of normal serum samples from 16 chicken and 20 mice
lacking antibodies to H7 was used to determine the
baseline of non-specific reduction in Mab 62 binding to
H7 antigen in the dual ELISA. Mean reduction of dual
ELISA readings was 6.5% for this serum panel, with a
standard deviation (SD) of 7.1. Specific blocking acti-
vities can be determined with 95% confidence if a
“cut-off value” of ≥30% is set for serum samples. The
latter was obtained by adding 3 SD to the mean 6.5%
blocking (6.5 + 21.3 = 27.8%). In the test, the dilution
factor of each serum sample at was recorded when itFigure 2 Specificity of H7 antigen detection in the dual ELISA. The sp
100 ul of PBS containing the H7 strains adjusted to an HA titer of 8 or non
absorbances of duplicate wells from two independent tests. OD 490: optica
without virus.presented ≥30% signal blocking rate. Additionally, the
blocking rate of each sample diluted at 20 times was
recorded for comparison.
Specificity and sensitivity of H7 antigen detection by the
dual-function-ELISA
The specificity of H7 antigen detection by the dual
ELISA was tested with 6 H7 strains from humans and
avian species and 13 representative non-H7 subtype
influenza virus strains from different regions and years,
including pandemic influenza and avian influenza virus
strains circulating in humans (Figure 2). Viruses of H7ecificity of H7 antigen detection in the dual-ELISA was examined with
-H7 viruses with HA titers of ≥16. Values represent the means of
l density at 490 nm; dotted line: cut-off values; Blank AF: allantoic fluid
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cued by reverse genetics with the six internal genes from
A/Puerto Rico/ 8/34. The reactivity and specificity of H7
antigen detection in the dual-ELISA were examined with
100 ul of PBS containing the H7 strains adjusted to an
HA titer of 8. Non-H7 viruses with HA titers of ≥16
were used in order to eliminate false-positive results. No
cross-reactivity was observed for any of the non-H7 sub-
type viruses tested.
The analytical sensitivity of H7 antigen detection in
the dual ELISA was determined against four different
H7 strains which had absorbance readings ranging from
0.7 to 1.3 at 8 HAU (Figure 3). The three selected H7
viruses were diluted serially for the determination of the
detection limit based on virus HA titer. With a cut-off
value of 0.2, the detection limit was determined to be
100 ul of sample containing 1 HA titer of virus (equal to
TCID50 10
3.2 of H7N7 A/Netherlands/219/03; TCID50
102.12 of H7N1 A/Chicken/Malaysia/94) for viruses that
had average and higher-than-average absorbance, while
it was 2 HA titers (equal to TCID50 10
2.354 of H7N6 A/
quail/Aichi/4/09) for viruses that had lower-than-aver-
age absorbance. The detection limit of HI test for
influenza virus was determined at 2 HAU (100 ul) and
subtype cross-reactivity were observed.Figure 3 Sensitivity of H7 antigen detection in the dual ELISA.
Tested viruses with an HA titer of 16 were twofold diluted and
subjected to the dual ELISA for antigen detection. Values represent
the means of absorbance of duplicate wells from two independent
tests. OD 490: optical density at 490 nm; dotted line: cut-off values.Specificity of H7 antibody detection by the dual-function-
ELISA
The specificity of the H7 detection by the dual ELISA was
investigated using a panel of antisera from experimentally
immunized chickens, mice and guinea pigs. Animal sera
collected 10 days after the 2nd immunization were first
diluted to obtain HI titer of 16 to the homologous virus to
normalize antibody concentrations prior to use in EB-
ELISA. Sera from chicken immunized with H7N1 influ-
enza viruses (Figure 4) presented ≥85% inhibition in Mab
62 binding, while sera from chickens immunized with
H1-H6 and H8-H13 showed maximum blocking of 10%,
well below the 30% threshold established for samples
containing H7 specific antibodies. No inhibition was
detected with sera immunized with wild type baculovirus.
Positive inhibition was also observed with all mouse sera
from individual immunizations with 4 different H7 strains,
indicating the assay is specific to detect H7 antibodies. All
animal sera from H7 immunization, including chicken,
mouse and guinea pigs, showed positive blocking in the
dual ELISA, indicating the assay is effective for sera from
any species. These results indicate that the antibody detec-
tion in the dual ELISA could positively identify serum
samples containing antibodies to H7 without any cross
reaction to sera from other subtypes.
Sensitivity of H7 antibody detection by the dual-function-
ELISA
The sensitivity of H7 antibody detection in the dual
ELISA was primarily determined by comparison to virus
neutralization and HI using purified Mab 62. As shown
in Table 3, in the dual ELISA, 40 ng of Mab 62 was suffi-
cient to reach the endpoint corresponding to a blocking
rate of more than 30%, while at least 160 ng of the same
Mab 62 was needed to neutralize 100 TCID50 of H7N7
(A/Netherlands/219/03) virus or inhibit hemagglutina-
tion. Additional comparisons of the dual ELISA and virus
neutralization in antibody detection were made using H7
immunized mice sera (Table 4). The neutralization titers
of mice sera after only one immunization with variant H7
AIV strains individually ranged from 40 to 320 against
H7N7 (A/Netherlands/219/03). The same batch of sera
was tested in the dual ELISA where the endpoint titers
ranged from 100 to 1000. No positive activity was detected
for pre-immunization serum samples by either test. The
comparison indicated that the dual ELISA was able to
detect a lower concentration of H7 specific antibody and
present a higher signal titer than virus neutralization.
Discussion
Increasing numbers of human infection and deaths
caused by H7N9 HPAI virus are currently reported in
China, making H7 subtype influenza virus one of the
most threatening flu pathogens. Successful control of H7
Figure 4 Specificity of H7 antibody detection in the dual ELISA. Sera from different animals immunized with different subtypes of influenza
viruses were collected 10 days after the 2nd immunization and normalized to a HI titer of 16 before tested in the dual ELISA. Inhibition above the
cut-off value of 30% blocking was considered as positive; i.e. antibodies to H7 were present. The results were expressed as the arithmetic mean of
percent blocking values. aH7N7: A/duck/Hokkaido/1/10; Ck: chicken; Gp: guinea pig; Ms: mouse; Bac: wildtype baculovirus immunized serum;
Blank: preimmune serum. Dotted line: cut-off values.
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serological surveillance of animals and humans. Despite
the advantages of conventional methods such as real
time PCR with high sensitivity and virus neutralization
with high specificity in influenza diagnosis, the main
drawback of these methods is their impracticality for
field investigation. In this study, a dual-function-ELISA
was developed to detect H7 AIVs by the combination of
AC-ELISA and blocking ELISA. The method allows the
specific and sensitive detection of both antigen and anti-
body of H7 AIVs with the same type and amount of
monoclonal antibodies. The dual-function-assay for H7
antigen and antibody detection provides a promising
prototype for a rapid test in an ever simplified format.
A specific and sensitive immunological assay relies on
good monoclonal antibodies. Both Mab 62 and 98 are
ofthe IgG1 isotype, which is optimal for large-scale
production and purification. The relevant amino acids in
the epitopes of Mab 62 and 98 were identified by the












5 ug 92.6% 5 ug 640 5 ug 256
1 ug 64.87% 1.25 ug 160 1.25 ug 64
0.2 ug 48.99% 0.313 ug 40 0.313 ug 16
0.04 ugb 31.05% 0.16 ugb 20 0.16 ugb 8
0.008 ug 12.84% 0.08 ug <20 0.08 ug <8
aHI and microneutralization assay based on a neutralizing Mab.
bThe detection limit of each test is indicated in bold and italics format.acids exist in all of the human H7 strains, including the
one from the recent outbreak in China, as confirmed
with virus neutralization and HI. The site targeted by
Mab 98 is within the 120-loop, a part of the receptor
binding site (RBS) [19] of H7, while Mab 62 recognizes
an epitope located between the 180-helix and 140-loop
of H7 HA1. The 180-helix is also part of the RBS and
the 140-loop contributes to the recognition of RBS [20].
Targeting to the RBS makes Mab 98 a neutralizing anti-
body with strong affinity to H7. The amino acid position
175 for Mab 62 is close to the H7 RBS but not within it.
This allows the amino acid to be conserved in neutra-
lizing epitopes.
Most patients infected with H7N9 HPAI viruses had a
history of poultry contact [21]. However, most avian spe-
cies carrying infectious H7N9 viruses are asymptomatic
[22]. Symptoms from H7N9 infection developed rapidly
and treatments are effective only when administrated
within 5 days after the onset of the symptoms [23,24].Table 4 Comparison between the dual-function-ELISA and
virus neutralization in antibody detection with pooled
mice sera after a single H7 immunization









H7N3/A/Canada/rv504/04 91.47% 500 160







Pre-immunization sera 4.14% <20 <20
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of infection is of crucial significance to identify in-
fections and reduce mortality in patients. This poses a
serious threat to public health and highlights the need
for H7 diagnosis. Further, less cases of avian infection
with H7N9 were reported than human cases, suggesting
there may be other reasons for human infection besides
poultry contacts. Serological assays are able to identify
the history of mild or asymptomatic infection in avian
species or humans, providing critical information for
surveillance studies [25]. Hence, efficient serological de-
tection in birds and humans is also important to control
and study H7 HPAI viruses. It was found previously that
poultry species carrying AIV antibodies are shedding less
virus than SPF poultry upon asymptomatic AIV infec-
tion or infection with mild microscopic lesions [26].
Therefore, ideally, diagnostic results of both antigen and
antibody detection should be consulted together to
create a better understanding of H7 infection among
populations. However, applying those high-tech diagno-
sis tests, such as Real time PCR and virus neutralization,
to routine screening in public populations and birds is
neither practical nor cost effective due to the limited
availability of equipment and trained manpower. User-
friendly rapid tests, such as dot ELISA and lateral flow,
are preferred in field investigation and clinical diagnosis
in the neighborhood [10,27]. All these immuno-tests are
initially developed from an ELISA assay based on mono-
clonal antibodies [9]. In the current study, AC-ELISA
and competitive ELISA were combined to a dual ELISA
with standardized Mabs for both H7 antigen and
antibody detection. High specificity and sensitivity were
confirmed for either function in the dual ELISA against
H7 AIVs. Sensitivity of antigen detection is higher than
HA tests and antibody ELISA detects less H7 antibodies
than conventional virus neutralization. The combination
of two functions in one plate paves the way for an ever
simplified rapid test. For antibody detection, the dual
ELISA is even easier to prepare than conventional
competitive ELISAs. A small amount of baculovirus ex-
pressed H7 antigen is sufficient for antibody blocking in
the dual ELISA while highly purified and concentrated
H7 antigen is required for coating in other cELISAs to
minimize unspecific blocking effects [12].
Conclusions
For the first time, the dual-function ELISA presented in
this study was proven to provide a fast, simple and cost-
effective platform for both antigen and antibody detec-
tion. The assay was highly sensitive and 100% specific in
both functions rendering it effective for H7 diagnosis.
Exploiting H7 specific neutralizing Mab 62 and 98
makes the H7 dual ELISA a more specific and sensitive
assay as compared to conventional immunological tests.A rapid test based on this H7 dual ELISA will serve as
effective tools for both H7 diagnosis and surveillance
investigation, meeting the needs to counter the ongoing
outbreak of H7N9 in China.
In conclusion, the dual-function ELISA presented in
this study was proven to provide a fast, simple and cost-
effective platform for both antigen and antibody detec-
tion. Exploiting H7 specific neutralizing Mab 62 and 98
makes the H7 dual ELISA a more specific and sensitive
assay as compared to conventional immunological tests.
A rapid test based on this H7 dual ELISA will serve as
effective tools for both H7 diagnosis and surveillance
investigation, meeting the needs to counter the ongoing
outbreak of H7N9 in China.
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